Harry Stylli, PhD

Stylli also serves Executive Chairman at Progenity, Inc., which provides complex molecular and specialized diagnostic tests for clinicians throughout the United States.  Dr. Stylli was previously employed as President & Chief Executive Officer by Sequenom, Inc., President & Chief Executive Officer by Xencor, Inc., President & Chief Executive Officer by CovX Research LLC, President by Aurora Biosciences Corp., and President by PanVera LLC. He also served on the board at Molecular Insight Pharmaceuticals, Inc. He received his undergraduate degree from the University of East London, an MBA from The Open University, and a doctorate degree from the University of London.